Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
6.44
-3.35
-52.02%
Share Warrants & Outstandings
Total Reserve
68.71
15.92
52.79
331.60%
Shareholder's Funds
71.80
22.36
49.44
221.11%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.11
0.09
0.02
22.22%
Other Long Term Liabilities
0.00
0.48
-0.48
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.11
0.57
-0.46
-80.70%
Current Liabilities
Trade Payables
38.70
3.26
35.44
1,087.12%
Other Current Liabilities
0.94
2.24
-1.30
-58.04%
Short Term Borrowings
9.91
7.41
2.50
33.74%
Short Term Provisions
0.02
0.00
0.02
0.00%
Total Current Liabilities
49.58
12.91
36.67
284.04%
Total Liabilities
121.49
35.83
85.66
239.07%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
11.24
5.61
49.91%
Less: Accumulated Depreciation
6.37
6.65
-0.28
-4.21%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
4.59
5.89
128.32%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
5.07
-4.32
-85.21%
Other Non Current Assets
3.46
0.00
3.46
0.00%
Total Non-Current Assets
18.13
9.66
8.47
87.68%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
6.07
31.94
526.19%
Sundry Debtors
56.54
12.24
44.30
361.93%
Cash and Bank
0.16
7.23
-7.07
-97.79%
Other Current Assets
0.17
0.00
0.17
0.00%
Short Term Loans and Advances
8.13
0.64
7.49
1,170.31%
Total Current Assets
103.36
26.17
77.19
294.96%
Net Current Assets (Including Current Investments)
53.78
13.27
40.51
305.28%
Total Current Assets Excluding Current Investments
103.00
26.17
76.83
293.58%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
35.83
85.66
239.07%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
7.41
2.50
33.74%
Book Value per share (adjusted)
232.39
34.73
197.66
569.13%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024






